Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP739039.RAymQCH2cmo6ticLuxJcsTToO40Z24P8xzyDNso69KoEs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP739039.RAymQCH2cmo6ticLuxJcsTToO40Z24P8xzyDNso69KoEs130_assertion type Assertion NP739039.RAymQCH2cmo6ticLuxJcsTToO40Z24P8xzyDNso69KoEs130_head.
- NP739039.RAymQCH2cmo6ticLuxJcsTToO40Z24P8xzyDNso69KoEs130_assertion description "[Human proximal tubular epithelial cells (PTEC) were pretreated with PPAR-gamma agonist, rosiglitazone, and/or angiotensin II (AngII) type 1 receptor (ATR1) blocker (ARB), losartan, followed by activation with the conditioned medium collected from human mesangial cells incubated with pIgA1 (IgA-HMC) from patients with IgAN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP739039.RAymQCH2cmo6ticLuxJcsTToO40Z24P8xzyDNso69KoEs130_provenance.
- NP739039.RAymQCH2cmo6ticLuxJcsTToO40Z24P8xzyDNso69KoEs130_assertion evidence source_evidence_literature NP739039.RAymQCH2cmo6ticLuxJcsTToO40Z24P8xzyDNso69KoEs130_provenance.
- NP739039.RAymQCH2cmo6ticLuxJcsTToO40Z24P8xzyDNso69KoEs130_assertion SIO_000772 19443277 NP739039.RAymQCH2cmo6ticLuxJcsTToO40Z24P8xzyDNso69KoEs130_provenance.
- NP739039.RAymQCH2cmo6ticLuxJcsTToO40Z24P8xzyDNso69KoEs130_assertion wasDerivedFrom befree-2016 NP739039.RAymQCH2cmo6ticLuxJcsTToO40Z24P8xzyDNso69KoEs130_provenance.
- NP739039.RAymQCH2cmo6ticLuxJcsTToO40Z24P8xzyDNso69KoEs130_assertion wasGeneratedBy ECO_0000203 NP739039.RAymQCH2cmo6ticLuxJcsTToO40Z24P8xzyDNso69KoEs130_provenance.